mycelium for anti-metastasis against lung cancer cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9198942
SERIAL NO

14461552

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A bioactive compound obtained from A. cinnamomea mycelium is prepared. The A. cinnamomea mycelium is solid-state cultivated. The bioactive compound is 2,3,6-trimethoxy-4-methylphenol and is called Leader 1. Leader 1 effectively suppresses movement, migration and invasion of lung cancer cells. Leader 1 achieves the effect of anti-metastasis and shows excellent resistance to physiological activity and mechanism on cancer metastasis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAIWAN LEADER BIOTECH CORP3F-1 NO 81 SEC 2 CHENGDE RD DATONG DIST TAIPEI CITY 103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Ching-Chun Taipei, TW 5 43
Kuo, Jong-Tar Taipei, TW 2 0
Lee, Jent-turn Taipei, TW 3 0
Lin, Chin-Chung Taipei, TW 24 115
Lin, Yu-Yen Taipei, TW 11 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00